Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
InChi: InChI=1S/C23H21ClN2O5/c1-30-22(28)14-9-7-13(8-10-14)21-20-16(15-5-3-4-6-17(15)25-20)11-18(23(29)31-2)26(21)19(27)12-24/h3-10
leading to the inhibition of metastasis
SKLB-610 inhibited angiogenesis-related tyrosine kinase VEGFR2
AST-1306 inhibits the enzymatic activities of wild-type epidermal growth factor receptor (EGFR) and ErbB2 as well as EGFR resistant mutant in both cell-free and cell-based systems
HAMI 3379 Size:Contact [email protected] for quotation InChi: InChI=1S/C23H21ClN2O5/c1-30-22(28)14-9-7-13(8-10-14)21-20-16(15-5-3-4-6-17(15)25-20)11-18(23(29)31-2)26(21)19(27)12-24/h3-10HAMI 3379 is a potent and selective CysLT2 receptor antagonist. HAMI 3379 has a protective effect on acute and subacute ischemic brain injury, and attenuates microglia related inflammation. Product information CAS Number: 1245653 57 9 Molecular Weight: 595. 72 Formula: C34H45NO8 Chemical Name: 3 {[(1R,3R) 3 carboxycyclohexyl]carbamoyl} 4 (3 {4 [4 (cyclohexyloxy)butoxy]phenyl}propoxy)benzoic acid Smiles:
US$ 4921.00
US$ 3092.75
US$ 4008.50
US$ 2934.57
US$ 125358.00
US$ 135.00
US$ 3181.35
US$ 3092.75
US$ 128987.50
US$ 3092.75
US$ 3499.47
US$ 3761.72
US$ 3181.35